Abstract:In the last thirty decade, with the emergence of new trends in molecular biology and advances in high-throughput technologies, much progress has been made in basic renal physiology. Molecular genetics has allowed the identification and elucidation of the structure, function and effects of the mutations of several of the main transporters and ion channels involved in renal disorders. Some renal stone disorders, such as cystinuria and Dent's disease, have been found to be due to mutations in genes SLC3A1 (type I) (See the section "Molecular biology and genotype-phenotype correlation in tubular dysfunction") and SLC7A9 (type II and type III), (See the section "Molecular biology and genotype-phenotype correlation in tubular dysfunction") and in CLC5, respectively. Liddle syndrome, a rare cause of hypertension, is now known to be caused by a mutation in tubular transport, due to a mutation in the SCNN1B gene, encoding for a Na+ channel protein (ENaC). Nevertheless, numerous issues remain unsettled and warrant additional research. These important advances and discoveries are not without limitations and challenges as changes in individual gene expression do not always translate into changes in its protein or protein modification. This raises proteomics as the most logical next step in our understanding of biological processes, as proteins from these deregulated genes are the functional agents in the cells. Proteomics takes a global and comprehensive view of a system, involving in many cases some notion of high throughput; but in contrast to genomics, there is no single biochemical method that can be used for the analysis of all proteins. Genomics and proteomics can complement each other in clinical applications by balancing the strengths and weaknesses of each individual technology. Several proteomics approaches have been exploited to shed more light on the molecular pathophysiology of several hereditary tubular disorders, such as Fanconi and Gitelman syndromes, and have provided important insights into the defective molecular mechanisms underlying these tubulopathies. Here we summarize several of the most important discoveries arising from molecular genetic and proteomic studies on hereditary tubular dysfunctions and show how these results can complement each other to increase our comprehension of these disorders at the molecular level.

Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states

Biology of the proximal tubule in body homeostasis and kidney disease

Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease

Renal proximal tubule cells: power and finesse

Proteomics and tubulopathies

Emerging Roles of Proximal Tubular Endocytosis in Renal Fibrosis

Role for Cannabinoid Receptors in Human Proximal Tubular Hypertrophy

Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease

Functioning and mechanisms of PTMs in renal diseases

Handling the sugar rush: The role of the renal proximal tubule

Tubulopathy meets Sherlock Holmes: biochemical fingerprinting of disorders of altered kidney tubular salt handling

Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease

Novel Mechanism for Tubular Injury in Nephropathic Cystinosis

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury

Angiotensin II and AT1a Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and Hypertension

[Exploration of renal tubular functions]

Is the Proximal Tubule the Focus of Tubulointerstitial Fibrosis?

Paracellular Transport and Renal Tubule Calcium Handling: Emerging Roles in Kidney Stone Disease

High glucose-induced downregulation of PTEN-Long is sufficient for proximal tubular cell injury in diabetic kidney disease

PTEN in kidney diseases: a potential therapeutic target in preventing AKI-to-CKD transition

The CTNS-MTORC1 axis couples lysosomal cystine to epithelial cell fate decisions and is a targetable pathway in cystinosis